eHealth, Inc.

As of October 31, 2025, eHealth, Inc. is considered very attractive due to its undervaluation indicated by a low P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, despite a year-to-date return of -44.89%, while showing strong long-term potential with a 3-year return of 85.00%.

As of October 31, 2025, eHealth, Inc. is considered very attractive due to its undervaluation, evidenced by a low P/E ratio of 6, a Price to Book Value of 0.20, and a PEG ratio of 0.02, especially when compared to its peer Abacus Life, Inc., which has a much higher P/E ratio of 164.30.

As of October 31, 2025, eHealth, Inc. is considered very attractive due to its undervaluation indicated by low P/E, Price to Book Value, and EV to EBITDA ratios, despite a recent stock decline, while its strong long-term returns suggest potential for recovery.

As of September 12, 2025, eHealth, Inc. is in a mildly bearish trend, with daily moving averages and Bollinger Bands indicating bearish momentum, despite some mild bullish signals from the MACD and KST, and it has significantly underperformed the S&P 500 with a year-to-date return of -57.87%.

As of July 7, 2025, eHealth, Inc. is considered very attractive in valuation due to its low P/E ratio of 6, Price to Book Value of 0.20, and EV to EBITDA ratio of 0.40, indicating significant undervaluation compared to peers like Abacus Life, Inc., despite a poor year-to-date stock performance of -57.87%.

As of May 7, 2025, eHealth, Inc. is considered a very attractive investment due to its undervalued status, with a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA ratio of 0.40, significantly lower than industry averages, despite a year-to-date decline of 57.55% compared to the S&P 500's 2.44% gain.

As of June 13, 2025, eHealth, Inc. is in a bearish trend, indicated by weak technical signals such as a bearish MACD, negative moving averages, and underperformance against the S&P 500.

As of March 2022, the management team of eHealth, Inc. includes CEO Scott Flanders and Lead Independent Director Jack Oliver, along with independent directors Andrea Brimmer, Beth Brooke-Marciniak, Michael Goldberg, and Randall Livingston.

eHealth, Inc. is a micro-cap company that offers an online platform for health insurance for individuals, families, and small businesses. As of March 2025, it reported net sales of $113 million and a net profit of $2 million.

As of Jun 18, eHealth, Inc. has a market capitalization of 171.75 million, with net sales of 552.57 million and a net profit of 28.99 million for the latest four quarters. The balance sheet as of December 2024 shows shareholder's funds of 925.94 million and total assets of 1,367.44 million.